APA (7th ed.) Citation

Hsueh, C., Billin, A., Li, S., Lin, S., Xiao, D., Chung, C., . . . Nelson, C. (2020). The pharmacokinetics, pharmacodynamics, and short-term safety of cilofexor, a nonsteroidal farnesoid X receptor agonist, in subjects with hepatic impairment. Journal of hepatology, 73, S444-S445. https://doi.org/10.1016/S0168-8278(20)31371-4

Chicago Style (17th ed.) Citation

Hsueh, Chia-Hsiang, Andrew Billin, Shirley Li, Stephen Lin, Deqing Xiao, Chuhan Chung, Robert Myers, Elijah Weber, and Cara Nelson. "The Pharmacokinetics, Pharmacodynamics, and Short-term Safety of Cilofexor, a Nonsteroidal Farnesoid X Receptor Agonist, in Subjects with Hepatic Impairment." Journal of Hepatology 73 (2020): S444-S445. https://doi.org/10.1016/S0168-8278(20)31371-4.

MLA (9th ed.) Citation

Hsueh, Chia-Hsiang, et al. "The Pharmacokinetics, Pharmacodynamics, and Short-term Safety of Cilofexor, a Nonsteroidal Farnesoid X Receptor Agonist, in Subjects with Hepatic Impairment." Journal of Hepatology, vol. 73, 2020, pp. S444-S445, https://doi.org/10.1016/S0168-8278(20)31371-4.